krypton has been researched along with Central Retinal Edema, Cystoid in 3 studies
Krypton: A noble gas that is found in the atmosphere. It has the atomic symbol Kr, atomic number 36, atomic weight 83.80, and has been used in electric bulbs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Between 1984 and 1988, 225 eyes of 132 patients were entered in a prospective, randomized clinical trial to determine if any significant differences exist between treatment with argon green (514 nm) and krypton red (647 nm) modified grid laser photocoagulation for patients with diffuse diabetic maculopathy with or without cystoid macular edema." | 9.06 | Argon green (514 nm) versus krypton red (647 nm) modified grid laser photocoagulation for diffuse diabetic macular edema. ( Olk, RJ, 1990) |
| "To evaluate the clinical effects of krypton yellow laser photocoagulation for cystoid macular edema (CME) in nonproliferative diabetic retinopathy (NPDR)." | 7.70 | [A clinical observation of krypton yellow laser photocoagulation for cystoid macular edema in nonproliferative diabetic retinopathy]. ( Bi, H; Liu, L; Wang, X; Yuan, M, 1999) |
| "Twenty patients with clinical and angiographic evidence of recent branch vein occlusion complicated by macular edema were assigned to receive krypton red laser treatment if their macular edema lasted more than three months." | 7.68 | Static and kinetic perimetry results of krypton red laser treatment for macular edema complicating branch vein occlusion. ( Ben-Sira, I; Hartman, B; Kremer, I; Siegal, R, 1990) |
| "Between 1984 and 1988, 225 eyes of 132 patients were entered in a prospective, randomized clinical trial to determine if any significant differences exist between treatment with argon green (514 nm) and krypton red (647 nm) modified grid laser photocoagulation for patients with diffuse diabetic maculopathy with or without cystoid macular edema." | 5.06 | Argon green (514 nm) versus krypton red (647 nm) modified grid laser photocoagulation for diffuse diabetic macular edema. ( Olk, RJ, 1990) |
| "To evaluate the clinical effects of krypton yellow laser photocoagulation for cystoid macular edema (CME) in nonproliferative diabetic retinopathy (NPDR)." | 3.70 | [A clinical observation of krypton yellow laser photocoagulation for cystoid macular edema in nonproliferative diabetic retinopathy]. ( Bi, H; Liu, L; Wang, X; Yuan, M, 1999) |
| "Twenty patients with clinical and angiographic evidence of recent branch vein occlusion complicated by macular edema were assigned to receive krypton red laser treatment if their macular edema lasted more than three months." | 3.68 | Static and kinetic perimetry results of krypton red laser treatment for macular edema complicating branch vein occlusion. ( Ben-Sira, I; Hartman, B; Kremer, I; Siegal, R, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, H | 1 |
| Liu, L | 1 |
| Wang, X | 1 |
| Yuan, M | 1 |
| Olk, RJ | 1 |
| Kremer, I | 1 |
| Hartman, B | 1 |
| Siegal, R | 1 |
| Ben-Sira, I | 1 |
1 trial available for krypton and Central Retinal Edema, Cystoid
| Article | Year |
|---|---|
Argon green (514 nm) versus krypton red (647 nm) modified grid laser photocoagulation for diffuse diabetic macular edema.
Topics: Adult; Aged; Aged, 80 and over; Argon; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; | 1990 |
2 other studies available for krypton and Central Retinal Edema, Cystoid
| Article | Year |
|---|---|
[A clinical observation of krypton yellow laser photocoagulation for cystoid macular edema in nonproliferative diabetic retinopathy].
Topics: Adult; Aged; Diabetic Retinopathy; Female; Humans; Krypton; Laser Coagulation; Macular Edema; Male; | 1999 |
Static and kinetic perimetry results of krypton red laser treatment for macular edema complicating branch vein occlusion.
Topics: Aged; Aged, 80 and over; Humans; Krypton; Laser Therapy; Macular Edema; Middle Aged; Postoperative C | 1990 |